Bayesian Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,381
Closed -$954K 161
2025
Q4
$954K Buy
14,381
+4,981
+53% +$322K 2.19% 6
2025
Q3
$633K Buy
+9,400
New +$744K 0.13% 236
2024
Q3
Sell
-5,600
Closed -$635K 772
2024
Q2
$635K Buy
+5,600
New +$708K 0.07% 314
2024
Q1
Sell
-54,036
Closed -$6.71M 857
2023
Q4
$6.71M Buy
54,036
+20,000
+59% +$2.04M 0.71% 18
2023
Q3
$3.18M Buy
34,036
+24,200
+246% +$2.73M 0.36% 67
2023
Q2
$1.26M Buy
+9,836
New +$1.19M 0.14% 207
2023
Q1
Sell
-8,403
Closed -$952K 873
2022
Q4
$952K Buy
+8,403
New +$923K 0.14% 194
2022
Q3
Sell
-7,000
Closed -$522K 774
2022
Q2
$522K Buy
7,000
+560
+9% +$51.1K 0.1% 325
2022
Q1
$824K Buy
+6,440
New +$704K 0.12% 250
2021
Q1
Sell
-26,000
Closed -$2.4M 574
2020
Q4
$2.4M Buy
26,000
+1,720
+7% +$154K 0.63% 29
2020
Q3
$2.5M Sell
24,280
-21,600
-47% -$2.26M 0.61% 31
2020
Q2
$4.65M Sell
45,880
-9,600
-17% -$859K 1.03% 8
2020
Q1
$3.73M Buy
55,480
+4,400
+9% +$274K 0.81% 4
2019
Q4
$2.79M Buy
+51,080
New +$2.42M 0.48% 38
2019
Q3
Sell
-20,000
Closed -$749K 560
2019
Q2
$749K Sell
20,000
-28,972
-59% -$911K 0.15% 187
2019
Q1
$1.46M Sell
48,972
-39,180
-44% -$1.38M 0.28% 105
2018
Q4
$2.64M Sell
88,152
-13,200
-13% -$419K 0.54% 34
2018
Q3
$3.62M Buy
101,352
+68,952
+213% +$2.14M 0.59% 30
2018
Q2
$769K Buy
+32,400
New +$687K 0.17% 158
2018
Q1
Sell
-106,500
Closed -$1.53M 636
2017
Q4
$1.53M Sell
106,500
-17,100
-14% -$222K 0.31% 85
2017
Q3
$1.51M Buy
+123,600
New +$2.18M 0.36% 77
2017
Q2
Sell
-27,600
Closed -$585K 474
2017
Q1
$585K Buy
+27,600
New +$539K 0.28% 128

Other funds holding DXCM